Residential College | false |
Status | 已發表Published |
High content screening for drug discovery from traditional Chinese medicine | |
Wang,Jing1; Wu,Ming Yue1; Tan,Jie Qiong2; Li,Min3; Lu,Jia Hong1 | |
2019-02-28 | |
Source Publication | Chinese Medicine |
ISSN | 1749-8546 |
Volume | 14Pages:5 |
Abstract | Traditional Chinese medicine (TCM) represents the crystallization of Chinese wisdom and civilization. It has been valued as the renewable source for the discovery of novel drugs, owing to its long-term proved efficacy in human diseases and abundant biologically active components pools. To dissect the mystery of TCM, modern technologies such as omics approaches (proteomics, genomics, metabolomics) and drug screening technologies (high through-put screening, high content screening and virtual screening) have been widely applied to either identify the drug target of TCM or identify the active component with certain bio-activity. The advent of high content screening technology has absolutely contributed to a breakthrough in compounds discovery and influenced the evolution of technology in screening field. The review introduces the concept and principle of high content screening, lists and compares the currently used HCS instruments, and summarizes the examples from ours and others research work which applied HCS in TCM-derived compounds screening. Meanwhile, this article also discusses the advantages and limitations of HSC technology in drug discovery from TCM libraries. |
Keyword | Advanced Models Drug Discovery High-content Screening Progressive Instruments Traditional Chinese Medicine |
DOI | 10.1186/s13020-019-0228-y |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Integrative & Complementary Medicine ; Pharmacology & Pharmacy |
WOS Subject | Integrative & Complementary Medicine ; Pharmacology & Pharmacy |
WOS ID | WOS:000460053400001 |
Scopus ID | 2-s2.0-85062333803 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | THE STATE KEY LABORATORY OF QUALITY RESEARCH IN CHINESE MEDICINE (UNIVERSITY OF MACAU) Institute of Chinese Medical Sciences |
Corresponding Author | Lu,Jia Hong |
Affiliation | 1.State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macao 2.Key Laboratory of Medical Genetics,Xiangya Medical School,Central South University,Changsha, Hunan,China 3.Mr. and Mrs. Ko Chi Ming Centre for Parkinson's Disease Research,School of Chinese Medicine,Hong Kong Baptist University,Hong Kong SAR,Hong Kong |
First Author Affilication | Institute of Chinese Medical Sciences |
Corresponding Author Affilication | Institute of Chinese Medical Sciences |
Recommended Citation GB/T 7714 | Wang,Jing,Wu,Ming Yue,Tan,Jie Qiong,et al. High content screening for drug discovery from traditional Chinese medicine[J]. Chinese Medicine, 2019, 14, 5. |
APA | Wang,Jing., Wu,Ming Yue., Tan,Jie Qiong., Li,Min., & Lu,Jia Hong (2019). High content screening for drug discovery from traditional Chinese medicine. Chinese Medicine, 14, 5. |
MLA | Wang,Jing,et al."High content screening for drug discovery from traditional Chinese medicine".Chinese Medicine 14(2019):5. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment